miR-379
rnamiR-379 suppresses vascular smooth muscle cell proliferation, influencing fibrous-cap integrity and atherosclerotic plaque stability.
Pathway placement
Cascade stepFibrous-cap degradation & rupture
Confidencemedium
RationaleInhibits VSMC proliferation; modulates fibrous-cap stability and plaque remodeling.
Also acts inVascular inflammation
Druggability
Not assessed (no mapped human gene target).
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood or cell-free plasma
Collection tube
PAXgene/Tempus RNA tube · K2/K3-EDTA (lavender-top)
Method / principle
RT-qPCR (TaqMan) or small-RNA sequencing
Reagent / substrate
Target-specific primers/probe; reverse transcriptase (miRNA: stem-loop RT primer)
Platform
qPCR instrument / NGS
Turnaround · availability
Research / send-out · Research (few LDTs)
Literature evidence(1)
- Circulating miR-379 as a potential novel biomarker for diagnosis of acute myocardial infarction.European review for medical and pharmacological sciences · 2018 · PMID 29424915 · doi